BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
1 hedge funds and large institutions have $553K invested in Biodexa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LOAMU
1
Lombard Odier Asset Management (USA)
New York
| $198K | – | – | – |
|
2
Renaissance Technologies
New York
| $176K | -$214K | -1 | Closed |
|
3
Morgan Stanley
New York
| $161K | -$155K | – | – |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $11K | -$13K | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $4K | – | – | – |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3.17K | -$3.78K | – | – |
|
7
Citadel Advisors
Miami,
Florida
| – | -$44K | – | – |
|